Evolving role of theophylline for treatment of chronic childhood asthma.
Szefler
S J
SJ
National Jewish Center for Immunology and Respiratory Medicine, Denver, CO 80206, USA.
Bender
B G
BG
Jusko
W J
WJ
Lanier
B Q
BQ
Lemanske
R F
RF
Skoner
D P
DP
Stempel
D A
DA
D000318:Adrenergic beta-Agonists / Q000627:therapeutic use; D001249:Asthma / Q000188:drug therapy*; D001507:Beclomethasone / Q000627:therapeutic use; D001993:Bronchodilator Agents / Q000627:therapeutic use; D002648:Child; D002986:Clinical Trials as Topic; D004205:Cromolyn Sodium / Q000627:therapeutic use; D006801:Humans; D009921:Metaproterenol / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D013806:Theophylline / Q000009:adverse effects / Q000627:therapeutic use*
D000318:Adrenergic beta-Agonists; D001993:Bronchodilator Agents; D009921:Metaproterenol; D013806:Theophylline; D001507:Beclomethasone; D004205:Cromolyn Sodium